Medical Internet Marketing Business Plan Leave a comment

DocBuzz, Inc., which specializes in medical marketing, is a company that focuses on pharmaceutical, biotechnical, and medical device details for the benefit of doctors. DocBuzz, Inc., a company that is exclusively for doctors and the medical community, is the only one of its kind. DocBuzz, Inc. was founded and managed by practicing physicians.

With revenue exceeding $96.3B annually, the pharmaceutical market ranks as one of the most profitable. The problem with the pharmaceutical industry is time. Time to research and develop, time for branding and marketing, time for sales and time to gain the trust of the medical profession. In this industry, time can be used to refer to money.

Similar situations exist in two other industries that produce similar products. Those industries are the biotech and the medical device companies. Although the revenues aren’t as large as those in the pharmaceutical business, they face intense competition within their individual industries.

DocBuzz, Inc., has developed a method that allows all of these industries to benefit from prelaunch marketing, product branding, and postlaunch sales support–all accomplished with the direct intervention of practicing physicians. DocBuzz, Inc. provides clients with the ability to market directly towards decision-makers, establishing credibility instantly through our extensive network and medical professionals. Our e-detailing service is the most cost-effective of all services. It offers live conference access, available 24 hours a days, seven days per week. Access to current information about various pharmaceutical products, biotech developments, medical devices, chat rooms and online marketing.

DocBuzz, Inc. will provide marketing services to the medical device, pharmaceutical, and biotech industries. We are physicians and have access to our colleagues immediately. For 75% of the budgets these industries currently have, we can communicate these companies’ message directly to decision makers. DocBuzz, Inc.’s unique incentive program will generate additional revenue for participating physicians and other doctors.

DocBuzz’s winning strategy is to give the best and most accurate information to the medical professionals. The industry can also use DocBuzz to promote, market and advertise their products through highly respected doctors. Individual professionals in the medical community will benefit from the latest industry information. They can also request samples and additional information via the internet. Professionals on our medical panel can earn points by participating in our e-detailing and/or by referral of others who join our program.

1. Keys to Success

DocBuzz, Inc. has identified four key strategies we believe are crucial for success:

1. New Internet technology has allowed for easier access to the prescription doctor to pharmaceuticals. This will allow for faster market acceptance and a more consistent prescribing pattern.
2. DocBuzz, Inc. employs a grass roots approach to recruiting and retaining participating prescribing doctors through a value incentivised referral program (VIRP). DocBuzz, Inc., a physician-owned company, is sensitive to physician’s needs and offers. In addition to the unique VIRP program, DocBuzz also offers other value added programs, such as CME, cyber meeting places, and other options for point redemption.
3. DocBuzz, Inc. offers evidence-based analysis that can be used to justify pharmaceutical investments in e-detailing.
4. DocBuzz, Inc., plans to grow aggressively but in a controlled manner, in order not to compromise the quality of its service.

1.2 Mission

DocBuzz, Inc. provides a reliable, high-quality alternative to in-house marketing and sales resources for pharmaceutical, biotechnical, and medical device manufacturers. DocBuzz, Inc., increases the return on investment in sales and marketing by speeding the physician learning curve for prelaunch, new, or existing products&#8211:through web access to educational details and marketing research. DocBuzz, Inc., is also beneficial to small, innovative biotechnology/pharmaceutical companies that don’t have extensive North American sales coverage.

1.3 Objectives